Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06223971 · ClinicalTrials.gov registry record · Early Phase 1
Long COVID-19 [11C]CPPC Study
A Early Phase 1 study of COVID Long-Haul, sponsored by Johns Hopkins University.
- Active
- Registry status
- Early Phase 1
- Development phase
- 6
- Enrollment target
- 1
- Study location
NCT06223971 is a Early Phase 1 study of COVID Long-Haul that is active but no longer recruiting, run by Johns Hopkins University. The registered enrollment target is 6 participants, below the 214-participant average among 4 other COVID Long-Haul trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06223971, a Early Phase 1 study of COVID Long-Haul, is active but no longer recruiting, sponsored by Johns Hopkins University.
- ACTIVE NOT RECRUITING
- Registry status
- Early Phase 1
- Development phase
- 6 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this study is to evaluate the safety of using the \[5-cyano-N-(4-(4-\[11C\]Methylpiperazin-1-yl)-2-(Piperidin-1-yl)Phenyl)Furan-2-carboxamide\] (\[11C\]CPPC) radiotracer in positron emission tomography (PET) imaging of people with history of COVID-19 infection, with and without symptoms. The investigators are also interested to see whether use of this radiotracer reveals imaging differences between patients with history of COVID-19 infection and still exhibiting symptoms or healthy patients with history of COVID-19 infection but exhibiting no current symptoms.
Conditions Studied
Interventions
- DRUG [11C]CPPC Injection
Study Locations (1)
Maryland
- Johns Hopkins Outpatient Center - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2024-08-06 |
| Est. Completion | 2026-03-31 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06223971
The ClinicalTrials.gov registry entry for NCT06223971 describes a study currently listed as active not recruiting, categorized as Early Phase 1. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 214-participant average among 4 other COVID Long-Haul trials with a reported enrollment target (97% lower). The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with COVID Long-Haul appearing as the primary indexed condition, and to 1 intervention - of which [11C]CPPC Injection is the first listed.
NCT06223971 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.
Frequently Asked Questions
What is clinical trial NCT06223971 about?
NCT06223971 is a clinical study titled "Long COVID-19 [11C]CPPC Study". The goal of this study is to evaluate the safety of using the \[5-cyano-N-(4-(4-\[11C\]Methylpiperazin-1-yl)-2-(Piperidin-1-yl)Phenyl)Furan-2-carboxamide\] (\[11C\]CPPC) radiotracer in positron emission tomography (PET) imaging of people with history of COVID-19 infection, with and without symptoms....
What is the current status of trial NCT06223971?
This trial is currently active not recruiting. It is a Early Phase 1 study. The enrollment target is 6 participants. The study started on 2024-08-06. Estimated completion is 2026-03-31.
What conditions does trial NCT06223971 study?
This clinical trial studies the following conditions: COVID Long-Haul.
What interventions are being tested in trial NCT06223971?
The interventions under investigation include: [11C]CPPC Injection (DRUG).
Who is sponsoring clinical trial NCT06223971?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06223971 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for COVID Long-Haul
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Percutaneous Electrical Nerve Field Stimulation (PENFS) in Patients With Post Concussion Syndrome (PCS)
RECRUITING · NA
-
Long-Covid-19 Alleviation Through Learning Mindfulness Study
RECRUITING · NA
-
Mind Body Intervention for Long COVID-19
RECRUITING · NA
-
Neural and Cognitive Consequences of COVID-19 Survival
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.